PER-001

· Perfuse Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PER-001, covering 2025-04-15 to 2025-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PER-001 in Participants With Open-Angle Glaucoma [Phase 1, Phase 2]